Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-27

Clinical Trial Update: Atrial Fibrillation Risk After Miniinvasive Mitral Valve Repair

View source ↗

Summary

A completed clinical trial evaluates the risk of atrial fibrillation after minimally invasive mitral valve repair for mitral regurgitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nemocnice AGEL Trinec-Podlesi a.s. | Conditions: Mitral Regurgitation, Computed Tomography | Status: COMPLETED